INFORMATION:
The study was supported by the National Cancer Institute (1R01CA172814-01).
Co-authors are Tatiana Andreyeva, PhD, director of economic initiatives of the Rudd Center at Yale University's University's Institution for Social and Policy Studies; and Joerg Luedicke of StataCorp.
About Columbia University's Mailman School of Public Health
Founded in 1922, Columbia University's Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 450 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,300 graduate students from more than 40 nations pursuing a variety of master's and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including ICAP (formerly the International Center for AIDS Care and Treatment Programs) and the Center for Infection and Immunity. For more information, please visit http://www.mailman.columbia.edu
Obesity-attributable absenteeism among US workers costs the nation more than $8 billion annually
2014-11-21
(Press-News.org) November 21, 2014 -- A study conducted by researchers at Columbia University's Mailman School of Public Health shows that obesity costs the U.S. $8.65 billion per year as a result of absenteeism in the workplace --more than 9% of all absenteeism costs. The consequences of obesity among the working population go beyond healthcare and create a financial challenge not only for the nation but for individual states as well. Findings are published online in the Journal of Occupational and Environmental Medicine.
The study is the first to provide state-level estimates of obesity-attributable costs of absenteeism among working adults in the U.S. In Wisconsin, for example, costs for obesity-related absences from the job cost the state $14.4 million; in California this figure rose to $907 million. "In areas where local wage level is higher or have high burden of obesity, the value of lost productivity really adds up," said Y. Claire Wang, MD, ScD, co-director of the Obesity Prevention Initiative at Columbia University's Mailman School of Public Health, and senior author.
To calculate the loss in worker productivity, researchers used nationally representative data about height, weight, and missed workdays for health reasons among 14,975 people from the National Health and Nutrition Examination Survey for the years 1998 to 2008. They also analyzed body mass index (BMI) data for 2012 by state for more than 100,000 people using the Behavioral Risk Factor Surveillance System.
"Obesity and healthy-living behaviors are often seen as just individual choices," noted Wang, Mailman School associate professor of Health Policy and Management. "But our paper really highlights the fact that the burden is beyond just individual choices."
Previous studies of this kind tend to focus on healthcare cost resulted from treating obesity-related illness which is only one dimension of its burden to the society. For instance, in 2011, Wang and her colleagues published a study in Lancet estimating a $66 billion higher medical expenditure by 2030 if the US trend in obesity continues. However, in thinking about obesity, especially severe obesity, as a threat to a competitive, healthy workforce, the authors present this problem as a priority from an economic standpoint. "Healthy community and healthy workers mean business." Wang said.
ELSE PRESS RELEASES FROM THIS DATE:
Immune checkpoint inhibitors may work in brain cancers
2014-11-21
Lugano/Geneva, Switzerland, 21 November 2014 - New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.
The novel research shows that brain metastases have dense concentrations of tumour infiltrating lymphocytes, providing an immunoactive environment. Moreover, both primary and secondary brain cancers often exhibit high expression of the immunosuppressive factor programmed cell death ligand 1 (PDL1), which can be inhibited ...
Life's extremists may be an untapped source of antibacterial drugs
2014-11-21
One of the most mysterious forms of life may turn out to be a rich and untapped source of antibacterial drugs.
The mysterious life form is Archaea, a family of single-celled organisms that thrive in environments like boiling hydrothermal pools and smoking deep sea vents which are too extreme for most other species to survive.
"It is the first discovery of a functional antibacterial gene in Archaea," said Seth Bordenstein, the associate professor of biological sciences at Vanderbilt University who directed the study, "You can't overstate the significance of the antibiotic ...
Research examines an emerging issue: Treatment of transgendered prison populations
2014-11-21
Prison policies vary on treating transgendered inmates, which could put inmates and institutions at risk. Gina Gibbs, a University of Cincinnati criminal justice doctoral student, will present a synopsis of the legal issues posed by such inmates at the annual meeting of the American Society of Criminology. The national conference runs from Nov. 19-22 in San Francisco.
At the center of the debate are Eighth Amendment protections against cruel and unusual punishment, widely varying policies on the treatment of transgendered populations and, Gibbs says, court crackdowns ...
Not all baseball stars treated equally in TV steroid coverage, says study of network news
2014-11-21
CHAMPAIGN, Ill. -- Retired baseball stars Barry Bonds, Mark McGwire and Rafael Palmeiro each had Hall of Fame-worthy numbers, each hitting more than 500 home runs.
All three also were tarred by allegations of steroid use.
Their stories, however, received very different treatment over 12 years of national television news coverage, says University of Illinois professor Brian Quick, lead author on a paper about that coverage and its effects, published online Nov. 20 by the journal Communication Research.
"We found that Bonds received more than twice as many negative stories ...
When shareholders exacerbate their own banks' crisis
2014-11-21
This news release is available in German. One lesson that policymakers and financial regulators have drawn from the financial market crisis is that banks need to be backed by more equity. But banks have found it hard to increase their core capital positions - in other words, the equity available to them long-term. Since 2009, this has led European banks to increasingly deploy an instrument that allows them to convert debt into equity in times of need: contingent convertible bonds, also known as CoCo bonds. Banks issue these bonds at fixed interest rates - as is normal ...
A coating that protects against heat and oxidation
2014-11-21
Gases don't conduct heat as well as solids do. Cellular or aerated concretes take advantage of this effect, which experts call "gas-phase insulation". The heat barrier is achieved by air encased in the cavities of the concrete. But gas-phase insulation has far greater potential than keeping our homes warm. It can also be used to protect turbine engine and waste incinerator components when subjected to intense heat. All you need to do is transfer this effect to a coating that is just a few hundred micrometers thick.
Temperature differences of over 400 degrees Celsius
Scientists ...
Type 2 diabetes: Added benefit of canagliflozin plus metformin is not proven
2014-11-21
The fixed combination of canagliflozin with metformin (trade name: Vokanamet) has been approved since April 2014 for adults with type 2 diabetes mellitus in whom diet and exercise do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) now examined in a dossier assessment whether the new drug combination offers an added benefit over the appropriate comparator therapy. No such added benefit can be derived from the dossier, however, because the manufacturer did not present any suitable data for any of the possible ...
Possibilities for personalized vaccines revealed at ESMO symposium
2014-11-21
Lugano/Geneva, Switzerland, 21 November 2014 - The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from Dr Harpreet Singh at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.
"One of the biggest hurdles in cancer immunotherapy is the discovery of appropriate cancer targets that can be recognised by T-cells," said Singh, who is scientific coordinator of the EU-funded GAPVAC phase I trial which is testing personalised vaccines in glioblastoma, the most common and aggressive brain cancer. "In the GAPVAC trial ...
New model of follow up for breast cancer patients
2014-11-21
Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health system perspective.
International guidelines recommend annual follow-up mammograms for every woman after treatment for early breast cancer, regardless of the risk of her cancer returning. There is also no strong evidence to support annual mammography compared with other possible mammography schedules.
In a paper published in the journal Value ...
Researchers study impact of power prosthetic failures on amputees
2014-11-21
VIDEO:
Powered lower limb prosthetics hold promise for improving the mobility of amputees, but errors in the technology may also cause some users to stumble or fall. New research from the...
Click here for more information.
Powered lower limb prosthetics hold promise for improving the mobility of amputees, but errors in the technology may also cause some users to stumble or fall. New research examines exactly what happens when these technologies fail, with the goal of developing ...